- Home
- XFOR vs CIA Comparison
XFOR vs CIA Comparison
Compare XFOR & CIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XFOR | CIA |
|---|---|---|
| Founded | 2014 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 324.4M | 259.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | XFOR | CIA |
|---|---|---|
| Price | $3.98 | $4.91 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $28.50 | N/A |
| AVG Volume (30 Days) | ★ 879.6K | 110.4K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.21 |
| Revenue | $33,979,000.00 | ★ $247,020,000.00 |
| Revenue This Year | $1,276.65 | $3.65 |
| Revenue Next Year | N/A | $3.51 |
| P/E Ratio | ★ N/A | $22.99 |
| Revenue Growth | ★ 2925.74 | N/A |
| 52 Week Low | $1.35 | $2.90 |
| 52 Week High | $26.83 | $6.36 |
Technical Indicators
Market Signals| Indicator | XFOR | CIA |
|---|---|---|
| Relative Strength Index (RSI) | 52.64 | 39.23 |
| Support Level | $3.50 | $4.95 |
| Resistance Level | $4.56 | $5.39 |
| Average True Range (ATR) | 0.30 | 0.34 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 47.91 | 0.00 |
Price Performance
Historical ComparisonAbout XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment. Company operates in USA, Columbia, Taiwan, Venezuela, Ecuador, Argentina, and Others.